Physician

Thomas A Salzer, M.D.

According to 2025 Medicare claims, Thomas Salzer, M.D. (NPI: 1558315739) practices otolaryngology in the College Station-Bryan, TX market, with the plurality of this provider's patient population coming from Brazos, TX. This provider's primary affiliated billing organization is CENTRAL TEXAS SINUS & ALLERGY, PLLC. (NPI: 1871919753; TIN: 464185930) and primary practice location at 77845-6080. Salzer is affiliated with the CommonSpirit ACO I (ACO ID: A2164), Main Street Rural Health Hickory ACO LLC (ACO ID: A5334), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Salzer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 642 traditional Medicare patients, billed 9,117 HCPCS/CPT codes, and received $306,582 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 1,070 prescription claims across 467 beneficiaries totaling $37,165 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 274 claims. Open Payments data shows 7 records totaling $192. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $219,086 and ending at $306,582. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $37,522 and ending at $37,165. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	764	6,524	$219,086
2016	807	6,767	$279,497
2017	757	4,993	$199,486
2018	951	7,906	$279,818
2019	832	6,951	$225,454
2020	556	4,703	$139,218
2021	527	4,967	$181,637
2022	641	5,664	$224,351
2023	704	7,697	$307,725
2024	642	9,117	$306,582

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	290	825	$37,522
2016	315	847	$29,422
2017	267	618	$18,589
2018	334	729	$54,749
2019	388	907	$29,250
2020	304	748	$24,543
2021	329	812	$20,836
2022	333	862	$24,496
2023	381	1,008	$55,260
2024	467	1,070	$37,165

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	127	417	$22,021
2016	130	458	$15,215
2017	135	375	$9,506
2018	118	331	$10,040
2019	80	227	$8,499
2020	65	243	$9,389
2021	54	186	$6,849
2022	80	304	$12,410
2023	61	267	$12,191
2024	64	274	$9,983

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	114	168	$129
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	358	639	$90
31575	Diagnostic exam of voice box using a flexible endoscope	107	130	$86
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	326	326	$71
69210	Removal of impacted ear wax	153	174	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	420	$8,958
Epinephrine	Epinephrine	23	1,092	$4,817
Ipratropium Bromide	Ipratropium Bromide	74	3,227	$1,922
Pantoprazole Sodium	Pantoprazole Sodium	162	7,092	$1,144
Fluticasone Propionate	Fluticasone Propionate	78	3,253	$1,125

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	25	$2,090
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	14	34	$1,773
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	28	$1,160
A7030	Full face mask used with positive airway pressure device, each	N	N/R	13	$1,108
A7031	Face mask interface, replacement for full face mask, each	N	N/R	12	$989

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$192	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas A. Salzer, M.D.?

Tedicare shows public-source Medicare data for Thomas A. Salzer, M.D. (NPI 1558315739), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas A. Salzer, M.D. have ACO affiliation data?

Thomas A. Salzer, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164), Main Street Rural Health Hickory ACO LLC (MSSP, ACO ID A5334), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Thomas A. Salzer, M.D.?

Thomas A. Salzer, M.D. is linked to CENTRAL TEXAS SINUS & ALLERGY, PLLC. (billing NPI 1871919753) in the available physician profile data.

Does Thomas A. Salzer, M.D. have Open Payments data?

Thomas A. Salzer, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.